DANDREA, Mario
 Distribuzione geografica
Continente #
NA - Nord America 236
EU - Europa 224
AS - Asia 75
AF - Africa 1
OC - Oceania 1
Totale 537
Nazione #
US - Stati Uniti d'America 236
GB - Regno Unito 120
CN - Cina 53
IT - Italia 19
FI - Finlandia 16
SE - Svezia 15
DE - Germania 14
FR - Francia 14
IE - Irlanda 14
SG - Singapore 9
BE - Belgio 7
VN - Vietnam 4
TR - Turchia 3
UA - Ucraina 3
IN - India 2
IR - Iran 2
AU - Australia 1
EE - Estonia 1
EG - Egitto 1
KR - Corea 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 537
Città #
Southend 119
Chandler 57
Jacksonville 41
Woodbridge 35
Ann Arbor 18
Dublin 14
Houston 11
New York 8
Shenyang 8
Beijing 7
Singapore 7
Brussels 6
Hebei 6
Lawrence 6
Princeton 6
Venice 5
Verona 5
Ashburn 4
Düsseldorf 4
Helsinki 4
Nanjing 4
Wilmington 4
Guangzhou 3
Jinan 3
Milan 3
Norwalk 3
Ardabil 2
Augusta 2
Changsha 2
Dong Ket 2
Kent 2
Ningbo 2
Tianjin 2
Zhengzhou 2
Cairo 1
Chicago 1
Chions 1
Dearborn 1
Delhi 1
Fairfield 1
Frankfurt am Main 1
Haikou 1
Hangzhou 1
Hanover 1
Jiaxing 1
Leawood 1
Liège 1
Melbourne 1
Mestre 1
Mogliano 1
Nanchang 1
Redmond 1
Riyadh 1
San Diego 1
San Francisco 1
Seoul 1
Taizhou 1
Tallinn 1
Xian 1
Totale 432
Nome #
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 101
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 95
Pancreatic cancer growth using magnetic resonance and bioluminescence imaging 93
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer. 88
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 85
Pancreatic cancer spheres are more than just aggregates of stem marker positive cells 76
Totale 538
Categoria #
all - tutte 1.593
article - articoli 1.593
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 7 3 0 6 7 6 4 5 3 10 4 3
2020/202153 6 6 2 3 7 3 3 5 5 0 9 4
2021/202250 4 12 0 1 2 1 2 2 3 4 4 15
2022/2023128 8 18 11 26 13 30 0 5 12 1 0 4
2023/202446 1 7 2 3 2 12 1 2 0 2 11 3
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 538